Pneumococcal Conjugate Vaccine impact assessment in Bangladesh

The study examines the impact of the introduction of 10-valent Pneumococcal Conjugate Vaccine (PCV10) into Bangladesh’s national vaccine program. PCV10 is administered to children under 1 year-old; the scheduled ages of administration are at 6, 10, and 18 weeks. The study is conducted in ~770,000 po...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Gates Open Res
Egile Nagusiak: Baqui, Abdullah H., McCollum, Eric D., Saha, Samir K., Roy, Arun K., Chowdhury, Nabidul H., Harrison, Meagan, Hanif, Abu Abdullah Mohammad, Simmons, Nicole, Mahmud, Arif, Begum, Nazma, Ahmed, Salahuddin, Khan, Ahad M., Ahmed, Zabed Bin, Islam, Maksuda, Mitra, Dipak, Quaiyum, Abdul, Chavez, Miguel A., Pervaiz, Farhan, Miele, Catherine H., Schuh, Holly B., Khanam, Rasheda, Checkley, William, Moulton, Lawrence H., Santosham, Mathuram
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: F1000 Research Limited 2018
Gaiak:
Study Protocol
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6030398/
https://ncbi.nlm.nih.gov/pubmed/29984359
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/gatesopenres.12805.1
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak